Mizuho Securities Downgrades Eagle Pharmaceuticals (EGRX) to Neutral; Stock to Plateau Post-Analyst Day
Tweet Send to a Friend
Mizuho Securities downgraded Eagle Pharmaceuticals (NASDAQ: EGRX) from Buy to Neutral while maintaining a $78 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
